Ultrasound-enhanced drug dispersion through solid tumours and itspossible role in aiding ultrasound-targeted cancer chemotherapy

Nikolitsa Nomikou, Ying Suet Li, Anthony McHale

Research output: Contribution to journalArticle

24 Citations (Scopus)

Abstract

It has been demonstrated that inadequate dispersion of cancer chemotherapeutic drugsthroughout the tissues of larger, relatively poorly vascularised tumours compromises thetherapeutic effectiveness of such drugs. Recently we demonstrated that electric fields couldbe exploited to achieve dispersion of a cancer chemotherapeutic drug through relativelyimpermeable tissues of a poorly vascularised solid tumour model. Using a modified SonidelSP100 sonoporator we demonstrate that ultrasound may enhance the toxicity of a cancerchemotherapeutic drug by dispersing the drug through relatively impermeable tissues of anon-vascularised tumour model in vivo. We suggest that such a phenomenon may play asignificant role in ultrasound targeting of cancer chemotherapeutic drugs, particularly inthe treatment of solid tumours.
LanguageEnglish
Pages94-98
JournalCancer Letters
Volume288
DOIs
Publication statusPublished - 1 Jan 2010

Fingerprint

Drug Therapy
Pharmaceutical Preparations
Neoplasms
Therapeutics

Cite this

@article{cf8c34015edf44f4bd4f5e8eaa9ef026,
title = "Ultrasound-enhanced drug dispersion through solid tumours and itspossible role in aiding ultrasound-targeted cancer chemotherapy",
abstract = "It has been demonstrated that inadequate dispersion of cancer chemotherapeutic drugsthroughout the tissues of larger, relatively poorly vascularised tumours compromises thetherapeutic effectiveness of such drugs. Recently we demonstrated that electric fields couldbe exploited to achieve dispersion of a cancer chemotherapeutic drug through relativelyimpermeable tissues of a poorly vascularised solid tumour model. Using a modified SonidelSP100 sonoporator we demonstrate that ultrasound may enhance the toxicity of a cancerchemotherapeutic drug by dispersing the drug through relatively impermeable tissues of anon-vascularised tumour model in vivo. We suggest that such a phenomenon may play asignificant role in ultrasound targeting of cancer chemotherapeutic drugs, particularly inthe treatment of solid tumours.",
author = "Nikolitsa Nomikou and Li, {Ying Suet} and Anthony McHale",
year = "2010",
month = "1",
day = "1",
doi = "10.1016/j.canlet.2009.06.028",
language = "English",
volume = "288",
pages = "94--98",

}

Ultrasound-enhanced drug dispersion through solid tumours and itspossible role in aiding ultrasound-targeted cancer chemotherapy. / Nomikou, Nikolitsa; Li, Ying Suet; McHale, Anthony.

Vol. 288, 01.01.2010, p. 94-98.

Research output: Contribution to journalArticle

TY - JOUR

T1 - Ultrasound-enhanced drug dispersion through solid tumours and itspossible role in aiding ultrasound-targeted cancer chemotherapy

AU - Nomikou, Nikolitsa

AU - Li, Ying Suet

AU - McHale, Anthony

PY - 2010/1/1

Y1 - 2010/1/1

N2 - It has been demonstrated that inadequate dispersion of cancer chemotherapeutic drugsthroughout the tissues of larger, relatively poorly vascularised tumours compromises thetherapeutic effectiveness of such drugs. Recently we demonstrated that electric fields couldbe exploited to achieve dispersion of a cancer chemotherapeutic drug through relativelyimpermeable tissues of a poorly vascularised solid tumour model. Using a modified SonidelSP100 sonoporator we demonstrate that ultrasound may enhance the toxicity of a cancerchemotherapeutic drug by dispersing the drug through relatively impermeable tissues of anon-vascularised tumour model in vivo. We suggest that such a phenomenon may play asignificant role in ultrasound targeting of cancer chemotherapeutic drugs, particularly inthe treatment of solid tumours.

AB - It has been demonstrated that inadequate dispersion of cancer chemotherapeutic drugsthroughout the tissues of larger, relatively poorly vascularised tumours compromises thetherapeutic effectiveness of such drugs. Recently we demonstrated that electric fields couldbe exploited to achieve dispersion of a cancer chemotherapeutic drug through relativelyimpermeable tissues of a poorly vascularised solid tumour model. Using a modified SonidelSP100 sonoporator we demonstrate that ultrasound may enhance the toxicity of a cancerchemotherapeutic drug by dispersing the drug through relatively impermeable tissues of anon-vascularised tumour model in vivo. We suggest that such a phenomenon may play asignificant role in ultrasound targeting of cancer chemotherapeutic drugs, particularly inthe treatment of solid tumours.

U2 - 10.1016/j.canlet.2009.06.028

DO - 10.1016/j.canlet.2009.06.028

M3 - Article

VL - 288

SP - 94

EP - 98

ER -